New brain imaging methods could sharpen diagnosis of neurological diseases
NCT ID NCT02053701
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to improve magnetic resonance spectroscopy (MRS), a type of brain scan that measures up to 18 different brain chemicals. Researchers are testing new methods at higher magnetic fields (3 to 7 Tesla) to get clearer and more detailed images. The study involves 30 healthy volunteers and focuses on technical development, not treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more precise brain scans for diagnosing and monitoring neurological diseases.
- What could go wrong
- This is a technical development study with only 30 healthy volunteers. It does not test any treatment, so benefits for patients are indirect and far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Magnetic Resonance Research
Minneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test